Supplements with their own beneficial effect on hosts are consumed by us. N-acetyl cysteine (NAC) and Vitamin C (Vit C) are antioxidants and supplements, consumed for their beneficial properties. The present investigation evaluates the effect of their antioxidant property on antibiotic efficacy against Escherichia coli cells from different physiological states, including exponential and stationary-phase, cell aggregates, and in-vitro stress-induced persister cells. Survival was measured in cfu/mL by cfu (colony-forming unit) counting, with efficacy determined by log-fold change in survival by comparing CFUs in antibiotics alone and antibiotic + antioxidant combinations. Fluoroquinolones in the presence of NAC reduced ∼1 log CFUs of log-phase and persister cells, while Vit C reduced CFUs (∼1–3-log increase) of cells from all physiological states. Aminoglycosides results were inconclusive; streptomycin’s activity declined (∼1–3-log increase in survival), whereas amikacin’s activity potentiated (∼1-log reduction in cfu/mL). Rifampicin’s showed reduced activity (∼2–3 log increase in survival) with Vit C in all the states and a ∼1–2 log increase with NAC, especially in cell aggregates and persisters. Beta-lactams activity showed variability, with amoxicillin and ampicillin not being influenced, but ceftriaxone showed significant reduction of efficacy (∼2–3-log increase in survival) in all the treatments. The findings suggest that the overall impact of antioxidants on antibiotic efficacy varies depending on the antibiotic class.
LoboV, PatilA, PhatakA, et al.Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev, 2010; 4(8):118–126; doi: 10.4103/0973-7847.70902
ManoharanA, OgnenovskaS, PainoD, et al.N-acetylcysteine protects bladder epithelial cells from bacterial invasion and displays antibiofilm activity against urinary tract bacterial pathogens. Antibiotics (Basel), 2021; 10(8):900; doi: 10.3390/antibiotics10080900
7.
HassunaNA, RabieEM, MahdWK, et al.Antibacterial effect of vitamin C against uropathogenic E. coli in vitro and in vivo. BMC Microbiol, 2023; 23(1):112; doi: 10.1186/s12866-023-02856-3
8.
PanditS, RavikumarV, Abdel-HaleemAM, et al.Low concentrations of vitamin C reduce the synthesis of extracellular polymers and destabilize bacterial biofilms. Front Microbiol, 2017; 8:2599; doi: 10.3389/fmicb.2017.02599
9.
MousaviS, BereswillS, HeimesaatMM. Immunomodulatory and antimicrobial effects of vitamin C. Eur J Microbiol Immunol (Bp), 2019; 9(3):73–79; doi: 10.1556/1886.2019.00016
10.
ChoiH, YangZ, WeisshaarJC. Single-cell, real-time detection of oxidative stress induced in Escherichia coli by the antimicrobial peptide CM15. Proceedings of the National Academy of Sciences, 2015; 112(3):E303–E10; doi: 10.1073/pnas.1417703112
11.
GoswamiM, MangoliSH, JawaliN. Involvement of reactive oxygen species in the action of ciprofloxacin against Escherichia coli. Antimicrob Agents Chemother, 2006; 50(3):949–954; doi: 10.1128/aac.50.3.949-954.2006
GoswamiM, MangoliSH, JawaliN. Effects of glutathione and ascorbic acid on streptomycin sensitivity of Escherichia coli. Antimicrob Agents Chemother, 2007; 51(3):1119–1122; doi: 10.1128/aac.00779-06
14.
Rodríguez-BeltránJ, CabotG, ValenciaEY, et al.N-acetylcysteine selectively antagonizes the activity of imipenem in Pseudomonas aeruginosa by an OprD-mediated mechanism. Antimicrob Agents Chemother, 2015; 59(6):3246–3251; doi: 10.1128/aac.00017-15
15.
Amábile-CuevasCF. Ascorbate and antibiotics, at concentrations attainable in urine, can inhibit the growth of resistant strains of Escherichia coli cultured in synthetic human urine. Antibiotics (Basel), 2023; 12(6):985; doi: 10.3390/antibiotics12060985
16.
KhamenehB, BazzazBS, AmaniA, et al.Combination of anti-tuberculosis drugs with vitamin C or NAC against different Staphylococcus aureus and Mycobacterium tuberculosis strains. Microb Pathog, 2016; 93:83–87; doi: 10.1016/j.micpath.2015.11.006
17.
BalabanNQ, MerrinJ, ChaitR, et al.Bacterial persistence as a phenotypic switch. Science, 2004; 305(5690):1622–1625; doi: 10.1126/science.1099390
18.
BalabanNQ, HelaineS, LewisK, et al.Definitions and guidelines for research on antibiotic persistence. Nat Rev Microbiol, 2019; 17(7):441–448; doi: 10.1038/s41579-019-0196-3
19.
VaishampayanA, GrohmannE. Antimicrobials functioning through ROS-mediated mechanisms: Current insights. Microorganisms, 2021; 10(1):61; doi: 10.3390/microorganisms10010061
20.
WuY, VulićM, KerenI, et al.Role of oxidative stress in persister tolerance. Antimicrob Agents Chemother, 2012; 56(9):4922–4926; doi: 10.1128/aac.00921-12
21.
SaitoK, MishraS, WarrierT, et al.Oxidative damage and delayed replication allow viable Mycobacterium tuberculosis to go undetected. Sci Transl Med, 2021; 13(621):eabg2612; doi: 10.1126/scitranslmed.abg2612
22.
SvenningsenMS, SvenningsenSL, SørensenMA, et al.Existence of log-phase Escherichia coli persisters and lasting memory of a starvation pulse. Life Sci Alliance, 2022; 5(2); doi: 10.26508/lsa.202101076
23.
ZuinR, PalamideseA, NegrinR, et al.High-dose N-acetylcysteine in patients with exacerbations of chronic obstructive pulmonary disease. Clin Drug Investig, 2005; 25(6):401–408; doi: 10.2165/00044011-200525060-00005
24.
SzkudlarekU, ZdziechowskiA, WitkowskiK, et al.Effect of inhaled N-acetylcysteine on hydrogen peroxide exhalation in healthy subjects. Pulm Pharmacol Ther, 2004; 17(3):155–162; doi: 10.1016/j.pupt.2004.01.007
25.
LykkesfeldtJ, Tveden-NyborgP. The pharmacokinetics of vitamin C. Nutrients, 2019; 11(10):2412; doi: 10.3390/nu11102412
KumarR, SinghN, ChauhanA, et al.Mycobacterium tuberculosis survival and biofilm formation studies: Effect of D-amino acids, D-cycloserine and its components. J Antibiot (Tokyo), 2022; 75(8):472–479; doi: 10.1038/s41429-022-00534-6
28.
KohanskiMA, DwyerDJ, CollinsJJ. How antibiotics kill bacteria: From targets to networks. Nat Rev Microbiol, 2010; 8(6):423–435; doi: 10.1016/j.cell.2007.06.049
29.
KhosraviMR, KhonshaM, RamazanzadehR. Combined effect of levofloxacin and N-acetylcysteine against Enterococcus faecalis biofilm for regenerative endodontics: An in vitro study. Iran Endod J, 2019; 14(1):40–46; doi: 10.22037/iej.v14i1.21245
30.
Kwiecińska-PirógJ, SkowronK, BogielT, et al.Vitamin C in the presence of sub-inhibitory concentration of aminoglycosides and fluoroquinolones alters Proteus mirabilis biofilm inhibitory rate. Antibiotics (Basel), 2019; 8(3):116; doi: 10.3390/antibiotics8030116
31.
AlbesaI, BecerraMC, BattánPC, et al.Oxidative stress involved in the antibacterial action of different antibiotics. Biochem Biophys Res Commun, 2004; 317(2):605–609; doi: 10.1016/j.bbrc.2004.03.085
32.
KoziolS, ZagulskiM, BilinskiT, et al.Antioxidants protect the yeast Saccharomyces cerevisiae against hypertonic stress. Free Radic Res, 2005; 39(4):365–371; doi: 10.1080/10715760500045855
33.
LandiniG, Di MaggioT, SergioF, et al.Effect of high N-acetylcysteine concentrations on antibiotic activity against a large collection of respiratory pathogens. Antimicrob Agents Chemother, 2016; 60(12):7513–7517; doi: 10.1128/aac.01334-16
34.
BockGR, YatesGK, MillerJJ, et al.Effects of N-acetylcysteine on kanamycin ototoxicity in the guinea pig. Hear Res, 1983; 9(3):255–262; doi: 10.1016/0378-5955(83)90030-8
35.
MarcheseA, BozzolascoM, GualcoL, et al.Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms. Int J Antimicrob Agents, 2003; 22(Suppl 2):95–100; doi: 10.1016/S0924-8579(03)00232-2
36.
KrauseKM, SerioAW, KaneTR, et al.Aminoglycosides: An overview. Cold Spring Harb Perspect Med, 2016; 6(6):a027029; doi: 10.1101/cshperspect.a027029
37.
ZhaoX, DrlicaK. Reactive oxygen species and the bacterial response to lethal stress. Curr Opin Microbiol, 2014; 21:1–6; doi: 10.1016/j.mib.2014.06.008
38.
FerreiraL, PosE, NogueiraDR, et al.Antibiotics with antibiofilm activity–Rifampicin and beyond. Front Microbiol, 2024; 15:1435720; doi: 10.3389/fmicb.2024.1435720
39.
WeinsteinZB, ZamanMH. Evolution of rifampin resistance in Escherichia coli and Mycobacterium smegmatis due to substandard drugs. Antimicrob Agents Chemother, 2019; 63(1):10–128; doi: 10.1128/AAC.01243-18
40.
PiccaroG, PietraforteD, GiannoniF, et al.Rifampin induces hydroxyl radical formation in Mycobacterium tuberculosis. Antimicrob Agents Chemother, 2014; 58(12):7527–7533; doi: 10.1128/aac.03169-14
41.
RanaSV, AttriS, VaipheiK, et al.Role of N-acetylcysteine in rifampicin-induced hepatic injury of young rats. World J Gastroenterol, 2006; 12(2):287–291; doi: 10.3748/wjg.v12.i2.287
42.
VilchèzeC, KimJ, Jacobs JrWR. Vitamin C potentiates the killing of Mycobacterium tuberculosis by the first-line tuberculosis drugs isoniazid and Rifampin in mice. Antimicrob Agents Chemother, 2018; 62(3):10–128; doi: 10.1128/aac.02165-17
43.
LégerL, Budin-VerneuilA, CacaciM, et al.β-lactam exposure triggers reactive oxygen species formation in Enterococcus faecalis via the respiratory chain component DMK. Cell Rep, 2019; 29(8):2184–2191.e3; doi: 10.1016/j.celrep.2019.10.080
44.
AminB, HajhashemiV, AbnousK, et al.Ceftriaxone, a beta-lactam antibiotic, modulates apoptosis pathways and oxidative stress in a rat model of neuropathic pain. Biomed Res Int, 2014; 2014(1):937568; doi: 10.1155/2014/937568
45.
BiswasS, HwangJ, KirkhamP, et al.Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease. Curr Med Chem, 2013; 20(12):1496–1530; doi: 10.2174/0929867311320120004
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
